WASHINGTON — Congress has reached agreement on the most sweeping overhaul of U.S. chemical safety laws in 40 years, a rare bipartisan accord that has won the backing of both industry officials and some of Capitol Hill’s most liberal lawmakers.

The compromise, which lawmakers unveiled Thursday, will provide the industry with greater certainty while empowering the Environmental Protection Agency to obtain more information about a chemical before approving its use. And because the laws involved regulate thousands of chemicals in products as diverse as detergents, paint thinners and permanent-press clothing, the result also will have a profound effect on Americans’ everyday lives.

The Toxic Substances Control Act, which has not been reauthorized since President Gerald Ford signed it into law in 1976, has come under sharp criticism from all quarters, including from environmentalists who back stronger federal oversight and from chemical companies that are now subject to a patchwork of more-stringent rules in some states.

The measure has the tacit approval of the Obama administration and the top Democrat on the Senate Environment and Public Works Committee, Barbara Boxer, D-Calif. It also has the backing of a broad coalition of industry, trial lawyers, public health advocates and many, though not all, environmental groups.

The measure could come up for a vote in both chambers as soon as next week. After passage, the EPA must start reviewing at least 10 toxic chemicals that permeate communities across the country, a list that is likely to include asbestos, formaldehyde and flame retardants. Many are interwoven into people’s experience with everyday products, including the ink on their morning newspaper and the fabric protector on their family’s sofa.

“People believe when they go to the grocery store and go to the hardware store and they get a product, that product’s been tested and that product’s safe,” Sen. Tom Udall, D-N.M., one of the key authors of the legislation, said at a news conference in front of the Capitol. “Well, that isn’t the case.”

Advertisement

Sen. Edward J. Markey, D-Mass., who worked on landmark measures revamping the Clean Air Act and the Superfund program and helped forge this week’s compromise on chemicals, said “it could be one of the most historic moments in environmental law in our country.”

The improbable deal, which both sides have pursued since President Obama’s first term in office, gives the EPA the power to require companies to provide health and safety data for untested chemicals and to prevent substances from reaching the market if they have not been determined to be safe.

Under current law, the agency must prove that a chemical poses a potential risk before it can demand data or require testing, and that substance can automatically enter the marketplace after 90 days.

In the past four decades, the EPA has required testing for just 200 of thousands of chemicals, and it has issued regulations to control only five of them. More than 8,000 chemicals are produced in the United States at an annual rate of more than 25,000 pounds each, according to the agency.

Under the bill, instead of going through a lengthy rulemaking process to trigger product testing, the EPA can order companies to test their new products. The measure also imposes user fees on industry to help expand the testing of chemicals.

In return, chemical manufacturers will be subject to a single regulatory system, although states will still have the right to seek a federal waiver to impose their rules on a given chemical. Currently, California, Maine, Maryland, Minnesota, New York, Oregon, Vermont and Washington have placed their own restrictions on some chemicals in the face of federal regulatory inaction.

American Chemistry Council President Cal Dooley, whose group represents dozens of chemical companies as well as major U.S. automakers and manufacturers of consumer goods, said his members were willing to disclose more information about their products in exchange for a more uniform standard.

“Not having one federal regulation guiding products onto the national marketplace is really problematic,” Dooley said. The bill “does strike what we see as an appropriate balance.”

Sen. David Vitter, R-Louisiana, who co-wrote the bill with Udall, said conservatives were motivated out of concern for public health and “the need to ensure that Americans remain on the cutting edge of science and innovation. That was threatened.”


Only subscribers are eligible to post comments. Please subscribe or login first for digital access. Here’s why.

Use the form below to reset your password. When you've submitted your account email, we will send an email with a reset code.